Overview
Assessment of Needs
The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing medical education (CME) effort for physicians on the evolving challenges of managing HIV disease. Risk for brain injury in patients with HIV infection and adherent to combination therapies persists despite suppression of plasma viremia. Among older patients, data support progressive atrophy, with abnormalities in brain integrity linked to the degree of systemic inflammation. This webinar will review current knowledge related to symptomatic cognitive impairment in patients who are virally suppressed. This webinar will also review the challenges of differentiating HIV-related cognitive impairment from Alzheimer’s disease among older people living with HIV. This diagnostic dilemma has emerged as one of the most challenging and pertinent clinical issue of our of the cART era.
Learning Objectives
On completion of this webinar, learners will be able to:
- Gain an appreciation for the characteristics and correlates of cognitive impairment in the current era
- Understand the challenges in distinguishing HIV-related cognitive impairment from that of Alzheimer’s disease
- Recognize possible directions for care among individuals with mild cognitive symptoms in the setting of HIV
Registration
Who Should Attend
This advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.
This activity is also relevant for registered nurses, PharmDs, and other health professionals.
Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.
Registration closes on Monday, August 5, 2019, 4:00 PM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.